文献速递头颈外科咽喉与嗓音

综合戒烟干预用于上呼吸消化道癌症放疗患者的初步随机对照试验

Pilot randomized controlled trial of a comprehensive smoking cessation intervention for patients with upper aerodigestive cancer undergoing radiotherapy.
PubMed 文献 · Head Neck · 2018-03-15

该初步随机对照试验将新型综合戒烟干预与强化常规护理进行比较,纳入接受放疗的头颈部或胸部恶性肿瘤吸烟患者。干预组戒烟调整OR为14.70(95%CI 3.56-60.76),吸烟量调整IRR为0.16(95%CI 0.06-0.40)。结论认为该干预可减少上呼吸消化道癌症患者放疗期间的吸烟。

要点

  • 干预组戒烟调整OR为14.70(95%CI 3.56-60.76)。
  • 干预组吸烟量调整IRR为0.16(95%CI 0.06-0.40)。

核心结论

  • 该综合戒烟干预可减少上呼吸消化道癌症患者放疗期间的吸烟。

研究设计与样本

  • 随机对照试验,比较新型综合戒烟干预与强化常规护理;干预组19例,对照组10例。
  • 研究对象为接受放疗的头颈部或胸部恶性肿瘤吸烟患者。
  • 对照组接受简短咨询,干预组接受强化咨询、药物治疗、短信和财务激励。
  • 主要比较8周生化确认7天戒烟率,采用Fisher精确检验;戒烟和吸烟强度另用时间序列面板回归分析。

主要发现

  • 干预组戒烟调整OR为14.70(95%CI 3.56-60.76)。
  • 干预组第1至8周吸烟量调整IRR为0.16(95%CI 0.06-0.40)。

关键数值与推荐

  • 戒烟调整OR 14.70(95%CI 3.56-60.76)。
  • 吸烟量调整IRR 0.16(95%CI 0.06-0.40)。

临床怎么用

  • 对接受放疗的上呼吸消化道癌症吸烟患者,可考虑采用包含强化咨询、药物治疗、短信和财务激励的综合戒烟干预。

局限性

  • 研究为初步随机对照试验,样本量小(干预组19例、对照组10例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Smoking among patients with cancer is associated with poor outcomes, however, smoking cessation interventions have had limited success. METHODS: This randomized controlled trial compared a novel smoking cessation intervention ("intervention") with enhanced usual care ("control"). Participants were smokers with head and neck or thoracic malignancies undergoing radiation. Controls received brief counseling. Intervention participants received intensive counseling, pharmacotherapy, text-messaging, and financial incentives. Biochemically confirmed 7-day abstinence at 8 weeks was compared using Fisher's exact t test. Smoking abstinence and intensity were also analyzed using time-series panel regression. RESULTS: The study population comprised 19 intervention and 10 control participants. More intervention (74%) than control (30%) participants abstained from smoking at 8 weeks (P = .05). Intervention participants were significantly more likely to abstain (adjusted odds ratio [OR] 14.70; 95% confidence interval [CI] 3.56-60.76) and smoked fewer cigarettes (adjusted incidence rate ratio [IRR], 0.16; 95% CI 0.06-0.40) during weeks 1 to 8. CONCLUSION: This intervention decreased smoking among patients with upper aerodigestive cancers during radiotherapy.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Rettig EM, Fakhry C, Hales RK, et al. Pilot randomized controlled trial of a comprehensive smoking cessation intervention for patients with upper aerodigestive cancer undergoing radiotherapy. Head Neck. 2018. PMID: 29542262. doi:10.1002/hed.25148

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。